INDUSTRY NEWS

00.001-MAR-2021-CW-002

Cancer research benefits from utilising Real-World Data (RWD)

  • “COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world evidence.”
  • “Another critical issue that real-world data is beginning to help solve is the lack of diversity in clinical trials…We use real-world data to explore differences in tumour biology. Treatment patterns, and outcomes to further characterise disparities in underrepresented and underserved populations.”
  • “Offering the highest quality oncology real-world data from leading academic and community-based cancer centers ensures that everyone touched by cancer has a clear path to the right care.”

Viraj Narayanan, Vice President of Life Sciences COTA inc.

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: MAR2021CW002